Enfortumab vedotin plus pembrolizumab followed by surgery showed high complete response rates in advanced urothelial cancer.

In case of recurrent vaginal cuff dehiscence, management options are limited. Our case report offers a laparoscopic treatment option ... risk factors for impaired wound healing were identified. She ...

(MENAFN- Quintile Reports) The Global Noninvasive Surgical Wound Closure Market was estimated at $6.01 billion in 2024 and is projected to reach $9.21 billion by 2034 , reflecting a robust CAGR of ...

Moreover, these scores can be used to distinguish patients at high risk for developing abdominal wound dehiscence that have similar diseases and undergo similar surgical procedures.

In a phase 3 trial, 81% of wounds treated with autologous cell sheet-based gene therapy showed ≥ 50% healing at 6 months, ...

The FDA has approved Zevaskyn for the treatment of recessive dystrophic epidermolysis bullosa, the company announced in a ...

UPMC has created a blueprint for treating patients experiencing gruesome side effects from drugs laced with xylazine.

Discover a study with has highlighted the potential of a novel silk elastin-based sponge as an effective wound treatment.

“We are excited to share insights with leading wound care providers and key opinion ... to drive awareness and adoption of our products in surgical settings, including gastrointestinal surgery.” ...

A Cleveland-based wound care service provider is establishing its first brick-and-mortar location after providing at-home care for the last eight months. Healix Wound Care aims to open its new space, ...